November 28, 2023
ZignSec is a technology group in the rapidly growing RegTech industry. The company provides a SaaS platform with real-time digital customer knowledge and ID verification solutions with global reach. The solutions are used by companies who in turn can optimise their processes to "onboard" both business customers and consumers while ensuring compliance with ever-changing local and global regulatory requirements for Know Your Customer (KYC) and Anti Money Laundering (AML).
» Read moreNovember 21, 2023
WntResearch is an oncology biotech company that develops new therapies to counteract the development of cancer metastases. The company’s research is focused on studying the endogenous protein WNT5A, which has been shown in scientific studies to affect the ability of tumor cells to move and spread in the body. WntResearch’s drug candidate Foxy-5 is a peptide that mimics the function of WNT5A with the aim of reducing the mobility and spread of cancer cells and thereby preventing metastases from occurring.
» Read moreOctober 12, 2023
Fragbite Group AB (publ) is a Swedish corporate group with a portfolio of established subsidiaries that develop, adapt and publish games and esports content within GAMING, ESPORTS and WEB3. Their products are developed for both traditional platforms – PC, mobile and console – and modern web3 platforms built on blockchain technology. The purpose of the directed issue is mainly to finance the acquisition of Fall Damage and the continued operation of Fall Damage and the development of its tactical First Person Shooter (“FPS”) game ALARA Prime until launch.
» Read moreJune 30, 2023
Medfield is a medical technology company that has developed the product MD100 Strokefinder, a device powered by AI and microwave technology that can distinguish stroke patients from healthy individuals and differentiate between strokes caused by a clot and those caused by a hemorrhage. By routing the patient directly to a stroke or trauma center, qualified treatment can be started much faster, leading to time savings, faster care, better outcomes, and lower healthcare costs. The company generates revenue through the sale of the MD100 system, software upgrades, service and maintenance, and disposable materials.
» Read moreJune 28, 2023
Moberg Pharma AB (publ) is a Swedish pharmaceutical company with a focus on the commercialization of proprietary medicines based on proven substances. The company's main asset is MOB-015 - a new topical treatment for nail fungus. Phase 3 clinical studies of more than 800 patients for MOB-015 indicate that the product has the potential to become the future market leader in onychomycosis. Moberg Pharma has agreements with commercial partners on site in Europe and Canada, among others. MOB-015 was recommended for market approval in the EU June 2023.
» Read moreJune 12, 2023
ZignSec is a RegTech company, providing an integrated end-to-end KYC, KYB compliance platform, facilitating seamless customer onboarding and monitoring, so clients can confidently expand operations internationally while remaining compliant. The platform is constantly evolving by addition of best-of-breed services and tools to enhance the customer experience. ZignSec has hundreds of customers spread across a range of industries where identification is essential, with the greatest concentration in financial services and other regulated activities.
» Read moreJune 7, 2023
AAC Clyde Space is a leading global small satellite specialist with the goal of becoming a world leader in providing high-quality and timely space data (Space Data as a Service), which can be applied to meet global challenges and improve life on Earth. To date, ~30 satellites have been designed, manufactured, and launched. AAC Clyde Space specializes in small satellite technologies and services that enable businesses, governments, and educational organizations to access high-quality, timely data from space.
» Read moreMay 17, 2023
ChromoGenics is a proptech company producing smart dynamic glass that improves indoor environments and well-being whilst lowering the buildings’ energy consumption, operating expenses and climate impact. The company’s product ConverLight® Dynamic is based on a unique patented technology from the Ångström Laboratory in Uppsala, where electrochromic coatings are sputtered onto plastic film. The result is a dynamic film that can be laminated between glass layers, which provides buildings with exceptional solar protection and lowered environmental impact from production,transport and use. The dynamic film is easy to transport and can be applied by local partners in the glass industry, which means it is possible to avoid long-distance and polluting shipping of bulky glass.
» Read moreMarch 4, 2023
ExpreS2ion Biotechnologies is a biotechnology company that develops vaccines based on complex proteins targeting infectious diseases and cancer. The company develops a pipeline of preventive and therapeutic vaccine products while generating revenue by outlicensing the company’s ExpreS2 platform. The lead candidate targeting COVID-19 is outlicensed to Bavarian Nordic, with positive phase II data announced in February 2022 and phase III initiated during September 2022. ExpreS2ion has a strong pipeline with multiple candidates in pre-clinical phase.
» Read moreFebruary 20, 2023
Immunovia is a diagnostics company with the vision to revolutionize blood-based diagnostics and increase the survival rate for patients with cancer. Immunovia has launched the first blood test in the world designed for the early detection of pancreatic cancer, a serious form of cancer with a low survival rate. The low survival rate is explained by the fact that pancreatic cancer is usually detected at a late stage when the tumor has metastasized. Immunovia has developed IMMray® PanCan-d, which is the first blood-based test specifically developed for the early diagnosis of pancreatic ductal adenocarcinoma (PDAC). Since 2016, Immunovia has conducted several large-scale studies targeting the main pancreatic cancer risk groups. Altogether, the studies have been conducted at around 30 hospitals in the USA and Europe and included several thousand patients. Based on the studies conducted, Immunovia's assessment is that IMMray® PanCan-d has unmatched clinical performance for the early detection of pancreatic cancer.
» Read moreFebruary 13, 2023
SciBase Holding is a MedTech company that develops point-of-care instruments for non-invasive detection of atopic dermatitis (eczema), skin cancer and other skin diseases. The products are based on the company’s technology platform that combines artificial intelligence (AI) with Electrical Impedance Spectroscopy (EIS), a technology based on more than 20 years of research at the Karolinska Institute. SciBase’s products include Nevisense and Nevisense Go and currently the platform is addressing detection of atopic dermatitis (eczema), melanoma and non-melanoma skin cancer. Nevisense is the only product that is approved by the Food and Drug Administration (FDA) for detection of melanoma and is the only instrument in Europe with a Medical Device Regulation (MDR) approval for detection of skin cancer.
» Read moreDecember 22, 2022
Trustscale AB and its operating subsidiary group Verisec International is a global encryption company with a tech platform used by banks and payment providers. Trustscale offers Payment Security and User Authentication to create trust between banks, payment providers, merchants, and consumers through safe digital transactions. A global regulatory paradigm shift now disrupts status quo and triggers payment encryption services to transform from today’s on premises, single client, market to a new outsourced, cloud based and globally scalable offering.
» Read moreDecember 21, 2022
Amniotics is a biopharma company focusing on mesenchymal stem cells (MSC) from amniotic fluid. The company was born out of the discovery of a novel source of stem cells in full-term amniotic fluid. Based on a decade of research at the internationally recognized Lund University Stem Cell Centre and the Skåne University Hospital of Lund, the company is pioneering the harvesting and propagation of tissue specific neonatal quality mesenchymal stem cells (MSC). These stem cells have unique properties for applications in regenerative medicine.
» Read moreNovember 24, 2022
SeaTwirl is a Swedish energy tech company in wind power with the vision to become global leader in floating offshore wind farms. SeaTwirl's unique floating vertical-axis wind turbine is simple and robust with few moving parts. This suits the conditions at sea and minimizes the need for maintenance, which leads to less downtime and operating hours. These are key requirements for reducing the costs associated with the production of energy. On the back of the successfully installed 30 kW prototype, S1, which has been operating efficiently since 2015, SeaTwirl is focusing on the development of SX, the next generation floating wind turbine with +10MW turbine power. In parallel with the development of SX, the company intends to continue improving efficiency and production of the S2x wind turbine in Norway.
» Read moreNovember 15, 2022
Stardots is a deep tech company that brings together engineers and mathematicians with neurologists and life-science developers. The company’s initial focus is on Parkinson Disease, where the company’s digital platform, ANLIVA™, through mathematical models, sensor data and AI, analyses typical symptoms through the patient’s smartphone. This is transformed into quantifiable symptom markers used for monitoring disease progression and optimizing treatment. Caregivers receive analysis, statistics and treatment suggestions based on the patient’s markers, allowing for individualized telemedicine treatment. Stardots’ vision is that its digital health platform ANLIVA™ will become a new standard for objective, equal, globally accessible, and cost-effective Parkinson’s care.
» Read moreNovember 9, 2022
WntResearch is a biotech company in oncology that develops the drug candidate Foxy-5 to prevent the development of cancer metastases. Foxy-5 is currently in the ongoing Phase 2 clinical study NeoFox. The study includes patients with colon cancer in stage II/III, who at diagnosis, according to established assessment criteria, are considered to have a high risk of recurrence after the primary tumor has been surgically removed. Foxy-5 is a peptide that mimics the function of the protein WNT5A which is found naturally in the body, a protein that prevents the spread of cancerous cells in the body.
» Read more